3-8766829-G-C
Variant names: 
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000916.4(OXTR):c.922+437C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: not found (cov: 32) 
Consequence
 OXTR
NM_000916.4 intron
NM_000916.4 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -0.0790  
Publications
34 publications found 
Genes affected
 OXTR  (HGNC:8529):  (oxytocin receptor) The protein encoded by this gene belongs to the G-protein coupled receptor family and acts as a receptor for oxytocin. Its activity is mediated by G proteins which activate a phosphatidylinositol-calcium second messenger system. The oxytocin-oxytocin receptor system plays an important role in the uterus during parturition. [provided by RefSeq, Jul 2008] 
 CAV3  (HGNC:1529):  (caveolin 3) This gene encodes a caveolin family member, which functions as a component of the caveolae plasma membranes found in most cell types. Caveolin proteins are proposed to be scaffolding proteins for organizing and concentrating certain caveolin-interacting molecules. Mutations identified in this gene lead to interference with protein oligomerization or intra-cellular routing, disrupting caveolae formation and resulting in Limb-Girdle muscular dystrophy type-1C (LGMD-1C), hyperCKemia or rippling muscle disease (RMD). Alternative splicing has been identified for this locus, with inclusion or exclusion of a differentially spliced intron. In addition, transcripts utilize multiple polyA sites and contain two potential translation initiation sites. [provided by RefSeq, Jul 2008] 
CAV3 Gene-Disease associations (from GenCC):
- caveolinopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
 - autosomal dominant limb-girdle muscular dystrophy type 1CInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
 - long QT syndrome 9Inheritance: AD Classification: MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
 - rippling muscle disease 2Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
 - distal myopathy, Tateyama typeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - inherited rippling muscle diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - Brugada syndromeInheritance: AD Classification: LIMITED Submitted by: Genomics England PanelApp
 - hypertrophic cardiomyopathy 1Inheritance: AD Classification: LIMITED Submitted by: PanelApp Australia
 - long QT syndromeInheritance: AD Classification: LIMITED Submitted by: ClinGen
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage; 
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87). 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  Cov.: 32 
GnomAD3 genomes 
Cov.: 
32
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  Cov.: 32 
GnomAD4 genome 
Cov.: 
32
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.